Founded in 1813, Yale Internal Medicine brings together an elite cadre of clinicians, investigators and educators in one of the world's top medical schools.
In 2025, @YaleCardiology's Stefania Nicoli, PhD, & team uncovered a specialized type of mRNA hidden inside focal adhesions.
Nicoli recently received a NIH Pioneer Award to develop a new kind of mRNA therapy. Learn more about her research.
https://t.co/luTMy7Onu7
In a recent study, @YalePCCSM researchers show how modifying the RNA extraction process in precision-cut lung slices can overcome interference from residual agarose, a gel-like substance needed to prepare the lung slices.
Learn more about the research.
https://t.co/y6cpfXzKOr
Yale researchers identified a previously unknown mechanism by which a nutrient abundant in red meat and commonly used in exercise supplements may amplify inflammation, which may offer a new direction for sepsis research.
https://t.co/j1d44DAloG
Meet postdoctoral fellow Brendan O’Brien, PhD, of @YaleCardiology, who is investigating the role of primary cilia in regulating smooth muscle differentiation and pathological vascular remodeling.
Learn more about O'Brien and what led him to Yale.
https://t.co/moIzikMyM6
A new study proposes a couples-based intervention to help prevent HIV acquisition among pregnant & postpartum women in South Africa.
The researchers say supporting male partners in HIV testing & linkage to care is a critical prevention strategy. More ⬇️
https://t.co/pW5z87tTsP
Dr. Jellyana Peraza, who finds inspiration in building strong relationships with her patients who have gastrointestinal conditions.
She joined @YaleDigestive in Sep '25 & she provides care to patients with a range of digestive disorders, including IBD.
https://t.co/PYDnX3UDKq
Rates of the metabolic dysfunction-associated steatotic liver disease (MASLD) continue to rise.
Although there are several treatment options, exercise plays an important role in preventing and managing the disease. Learn more from Dr. David Feldshon.
https://t.co/qnrKeSHWdz
The department is kicking off a new series, Lead, Empower, Advance, Develop (LEAD), that aims to bring inspiring speakers & candid conversations about leadership to faculty, staff, and trainees.
Learn more and add the virtual sessions to your calendar!
https://t.co/4yP2dyfcL7
The department is pleased to highlight its newly promoted professors:
• Kathleen Akgun, MD, MS
• David Calfee, MD, MS
• Stefania Nicoli, PhD
Learn more about each of them, including what their promotions mean to them and what they're most proud of.
https://t.co/HKG2FNEExm
Dr. Carol Williams is a clinical fellow in @YaleADM who chose Yale after observing the physicians’ compassionate, thoughtful & evidence-based approach during a visiting elective.
She aspires to build a career that integrates family & addiction medicine.
https://t.co/jgcSa2Q5eb
The department held its first inaugural Gary V. Désir Lecture featuring physician-scientist Dr. Richard Kibbey.
Kibbey presented, “Mitochondrial Satiety: Implications for the Treatment of Obesity."
Learn more about the lecture and Kibbey's presentation.
https://t.co/qCgrpcqZOJ
A new Yale study investigates the impact of antimalarial medications on mosquitoes and found that the drugs did not affect mosquito survival, feeding behavior, or reproduction.
Learn more.
https://t.co/PDYHAx6f5w
.@YaleNephrology researchers used advanced cell profiling techniques to obtain the most detailed view of how kidney & immune cells interact in acute interstitial nephritis.
These findings may help improve AIN treatment, as current options remain limited.
https://t.co/bWSUQfOdcs
Meet Christine Abu-Hanna, program manager for the Yale Liver Center.
Abu-Hanna has been at Yale since 2013, and enjoys that her role is rewarding and the work she does supports something bigger.
Learn more about her ⬇️
https://t.co/tK90vgO2ZN
A study compared 9 clinical risk scores for assessing patients w/ steatotic liver disease.
They found FIB-4, APRI & the Steatotic-Associated Fibrosis Estimator (SAFE) were among the best at distinguishing patients who would develop cirrhosis w/in 10 yrs.
https://t.co/2uVbNqeyfJ
ATTN YALE: The Diabetes Research Center is accepting applications for pilot and feasibility project grants for diabetes or metabolism-related studies.
Learn more about eligibility, the application process, and the deadline in the story below.
https://t.co/qNsFFDEBwz
Dr. George Goshua was one of 10 academic physicians to be named to the 2026-2027 JAMA Editorial Fellowship Program. Learn more.
@GeorgeGoshuaMD
https://t.co/GK7GtifLtr
Physician-scientists are testing CAR-T therapy in clinical trials for autoimmune diseases, including lupus, multiple sclerosis & scleroderma.
Learn more about how CAR-T therapy works and is beginning to move beyond oncology.
https://t.co/Bi0Cys8WcT
Meet Christopher Kiang, MD, clinical fellow in @YalePCCSM, who plans to use computational methods to better classify pulmonary fibrosis subtypes and identify patients at high risk for disease progression.
Learn more about Kiang.
https://t.co/oix3DIDYnR
Dr. Yasuko Iwakiri researches the underlying causes of liver disease. She studies portal hypertension, a serious complication of advanced chronic liver disease.
Iwakiri’s lab researches liver disease through surgical and molecular approaches.
https://t.co/DGbJ9B3caF